Literature DB >> 22538930

Ellagic acid attenuates high-carbohydrate, high-fat diet-induced metabolic syndrome in rats.

Sunil K Panchal1, Leigh Ward, Lindsay Brown.   

Abstract

BACKGROUND: Fruits and nuts may prevent or reverse common human health conditions such as obesity, diabetes and hypertension; together, these conditions are referred to as metabolic syndrome, an increasing problem. This study has investigated the responses to ellagic acid, present in many fruits and nuts, in a diet-induced rat model of metabolic syndrome.
METHODS: Eight- to nine-week-old male Wistar rats were divided into four groups for 16-week feeding with cornstarch diet (C), cornstarch diet supplemented with ellagic acid (CE), high-carbohydrate, high-fat diet (H) and high-carbohydrate, high-fat diet supplemented with ellagic acid (HE). CE and HE rats were given 0.8 g/kg ellagic acid in food from week 8 to 16 only. At the end of 16 weeks, cardiovascular, hepatic and metabolic parameters along with protein levels of Nrf2, NF-κB and CPT1 in the heart and the liver were characterised.
RESULTS: High-carbohydrate, high-fat diet-fed rats developed cardiovascular remodelling, impaired ventricular function, impaired glucose tolerance, non-alcoholic fatty liver disease with increased protein levels of NF-κB and decreased protein levels of Nrf2 and CPT1 in the heart and the liver. Ellagic acid attenuated these diet-induced symptoms of metabolic syndrome with normalisation of protein levels of Nrf2, NF-κB and CPT1.
CONCLUSIONS: Ellagic acid derived from nuts and fruits such as raspberries and pomegranates may provide a useful dietary supplement to decrease the characteristic changes in metabolism and in cardiac and hepatic structure and function induced by a high-carbohydrate, high-fat diet by suppressing oxidative stress and inflammation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22538930     DOI: 10.1007/s00394-012-0358-9

Source DB:  PubMed          Journal:  Eur J Nutr        ISSN: 1436-6207            Impact factor:   5.614


  40 in total

1.  Insulin resistance and nonalcoholic steatohepatitis: fat or fiction?

Authors:  A J Sanyal
Journal:  Am J Gastroenterol       Date:  2001-02       Impact factor: 10.864

2.  Olive leaf extract attenuates cardiac, hepatic, and metabolic changes in high carbohydrate-, high fat-fed rats.

Authors:  Hemant Poudyal; Fiona Campbell; Lindsay Brown
Journal:  J Nutr       Date:  2010-03-24       Impact factor: 4.798

3.  In vitro anti-proliferative activities of ellagic acid.

Authors:  Jack N Losso; Rishipal R Bansode; Alfred Trappey; Hiba A Bawadi; Robert Truax
Journal:  J Nutr Biochem       Date:  2004-11       Impact factor: 6.048

4.  Role of ellagic acid against cisplatin-induced nephrotoxicity and oxidative stress in rats.

Authors:  Ahmet Ateşşahín; Ali Osman Ceríbaşi; Abdurrauf Yuce; Ozgür Bulmus; Gürkan Cikim
Journal:  Basic Clin Pharmacol Toxicol       Date:  2007-02       Impact factor: 4.080

5.  Pharmacodynamics of ellagic acid on cardiac troponin-T, lyosomal enzymes and membrane bound ATPases: mechanistic clues from biochemical, cytokine and in vitro studies.

Authors:  M Mari Kannan; S Darlin Quine
Journal:  Chem Biol Interact       Date:  2011-07-05       Impact factor: 5.192

6.  Oxidative stress is independently associated with non-alcoholic fatty liver disease (NAFLD) in subjects with and without type 2 diabetes.

Authors:  Sandhya Narasimhan; Kuppan Gokulakrishnan; Rangasamy Sampathkumar; Syed Farooq; Radhakrishnan Ravikumar; Viswanathan Mohan; Muthuswamy Balasubramanyam
Journal:  Clin Biochem       Date:  2010-04-14       Impact factor: 3.281

Review 7.  Metabolic syndrome and non-alcoholic fatty liver disease.

Authors:  Paloma Almeda-Valdés; Daniel Cuevas-Ramos; Carlos Alberto Aguilar-Salinas
Journal:  Ann Hepatol       Date:  2009       Impact factor: 2.400

8.  Dose translation from animal to human studies revisited.

Authors:  Shannon Reagan-Shaw; Minakshi Nihal; Nihal Ahmad
Journal:  FASEB J       Date:  2007-10-17       Impact factor: 5.191

9.  Improvement of cisplatin-induced injuries to sperm quality, the oxidant-antioxidant system, and the histologic structure of the rat testis by ellagic acid.

Authors:  Gaffari Türk; Ahmet Ateşşahin; Mustafa Sönmez; Ali Osman Ceribaşi; Abdurrauf Yüce
Journal:  Fertil Steril       Date:  2007-08-06       Impact factor: 7.329

Review 10.  Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications.

Authors:  Elisa Fabbrini; Shelby Sullivan; Samuel Klein
Journal:  Hepatology       Date:  2010-02       Impact factor: 17.425

View more
  44 in total

Review 1.  Improvements in Metabolic Health with Consumption of Ellagic Acid and Subsequent Conversion into Urolithins: Evidence and Mechanisms.

Authors:  Inhae Kang; Teresa Buckner; Neil F Shay; Liwei Gu; Soonkyu Chung
Journal:  Adv Nutr       Date:  2016-09-15       Impact factor: 8.701

2.  Arctic berry extracts target the gut-liver axis to alleviate metabolic endotoxaemia, insulin resistance and hepatic steatosis in diet-induced obese mice.

Authors:  Fernando F Anhê; Thibault V Varin; Mélanie Le Barz; Geneviève Pilon; Stéphanie Dudonné; Jocelyn Trottier; Philippe St-Pierre; Cory S Harris; Michel Lucas; Mélanie Lemire; Éric Dewailly; Olivier Barbier; Yves Desjardins; Denis Roy; André Marette
Journal:  Diabetologia       Date:  2017-12-21       Impact factor: 10.122

Review 3.  Herbal medicines and nonalcoholic fatty liver disease.

Authors:  Hong Yao; Yu-Jie Qiao; Ya-Li Zhao; Xu-Feng Tao; Li-Na Xu; Lian-Hong Yin; Yan Qi; Jin-Yong Peng
Journal:  World J Gastroenterol       Date:  2016-08-14       Impact factor: 5.742

Review 4.  How poverty affects diet to shape the microbiota and chronic disease.

Authors:  Christy A Harrison; Douglas Taren
Journal:  Nat Rev Immunol       Date:  2017-11-07       Impact factor: 53.106

Review 5.  Dietary natural products as epigenetic modifiers in aging-associated inflammation and disease.

Authors:  Levi W Evans; Matthew S Stratton; Bradley S Ferguson
Journal:  Nat Prod Rep       Date:  2020-01-29       Impact factor: 13.423

6.  Luteolin alleviates cardiac ischemia/reperfusion injury in the hypercholesterolemic rat via activating Akt/Nrf2 signaling.

Authors:  Jin-Ting Yang; Jue Wang; Xin-Ru Zhou; Chi Xiao; Yang-Yun Lou; Li-Hui Tang; Feng-Jiang Zhang; Ling-Bo Qian
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-04-18       Impact factor: 3.000

Review 7.  Therapeutic Potential of Pomegranate in Metabolic Disorders.

Authors:  Maryam Akaberi; Zahra Boghrati; Amirhossein Sahebkar; Seyed Ahmad Emami
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 8.  Red Raspberries and Their Bioactive Polyphenols: Cardiometabolic and Neuronal Health Links.

Authors:  Britt M Burton-Freeman; Amandeep K Sandhu; Indika Edirisinghe
Journal:  Adv Nutr       Date:  2016-01-15       Impact factor: 8.701

9.  Improving Effect of Ellagic Acid on Sleep Quality and Gastrointestinal Symptoms in Patient With Irritable Bowel Syndrome: Randomized Double-Blind Clinical Trial.

Authors:  Zahra Mirzaie; Ali Bastani; Sepideh Hesami; Elahe Pouryousefi; Maria Kavianpour; Hossein Khadem Haghighian
Journal:  Turk J Gastroenterol       Date:  2021-11       Impact factor: 1.852

Review 10.  Review of Functional and Pharmacological Activities of Berries.

Authors:  Oksana Golovinskaia; Chin-Kun Wang
Journal:  Molecules       Date:  2021-06-25       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.